These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 8732362

  • 1. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
    Hawser S.
    J Med Vet Mycol; 1996; 34(2):149-52. PubMed ID: 8732362
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A, Saddi M, Cardia MC, Borgna R, Sanna C, Saddi B, Maccioni E.
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [Abstract] [Full Text] [Related]

  • 4. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
    Brenciaglia MI, Ghezzi MC, Cipriani P, Mancini C, Trancassini M.
    Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adhesion of different Candida spp. to plastic: XTT formazan determinations.
    Hawser S.
    J Med Vet Mycol; 1996 Jun; 34(6):407-10. PubMed ID: 8971630
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antifungal drug susceptibility of oral Candida albicans isolates may be associated with apoptotic responses to Amphotericin B.
    Yang C, Gong W, Lu J, Zhu X, Qi Q.
    J Oral Pathol Med; 2010 Feb; 39(2):182-7. PubMed ID: 19656268
    [Abstract] [Full Text] [Related]

  • 10. Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B.
    Rukayadi Y, Lee K, Lee MS, Yong D, Hwang JK.
    FEMS Yeast Res; 2009 Dec; 9(8):1302-11. PubMed ID: 19663917
    [Abstract] [Full Text] [Related]

  • 11. [Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans].
    Urbanowski S, Nierebińska E, Gwieździński Z.
    Przegl Dermatol; 1989 Dec; 76(5-6):405-9. PubMed ID: 2561925
    [Abstract] [Full Text] [Related]

  • 12. Candida albicans viability after exposure to amphotericin B: assessment using metabolic assays and colony forming units.
    Khot PD, Suci PA, Tyler BJ.
    J Microbiol Methods; 2008 Mar; 72(3):268-74. PubMed ID: 18234380
    [Abstract] [Full Text] [Related]

  • 13. In vitro synergistic activity of ketoconazole with valproic acid against Candida species.
    Krajewska-Kułak E, Niczyporuk W.
    Arzneimittelforschung; 1996 Sep; 46(9):934-6. PubMed ID: 8876946
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. AmBisome and Amphotericin B inhibit the initial adherence of Candida albicans to human epithelial cell lines, but do not cause yeast detachment.
    Dorocka-Bobkowska B, Düzgüneş N, Konopka K.
    Med Sci Monit; 2009 Sep; 15(9):BR262-9. PubMed ID: 19721394
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA.
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [Abstract] [Full Text] [Related]

  • 18. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
    Linares MJ, Muñoz JF, Solís F, Rodríguez FC, Valero A, Casal M.
    Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292
    [Abstract] [Full Text] [Related]

  • 19. Impact of endpoint definition on the outcome of antifungal susceptibility tests with Candida species: 24- versus 48-h incubation and 50 versus 80% reduction in growth.
    St-Germain G.
    Mycoses; 2001 Mar; 44(1-2):37-45. PubMed ID: 11398639
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of antifungal combinations against planktonic and sessile cells of Candida albicans isolated from medical devices in an intensive care department.
    Touil HFZ, Boucherit-Otmani Z, Boucherit K.
    J Mycol Med; 2018 Sep; 28(3):414-418. PubMed ID: 30032993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.